"Strategic Future ▪ SUDA will continue to source, evaluate and acquire new technologies ▪ Continue to expand the team with deep Biotechnology/Drug Development/Pharma experience ▪ Build out the intellectual property portfolio – patents and knowhow ▪ Build out the OroMist platform to reformulate existing billion-dollar drugs for oral delivery by creating partnerships with big pharma ▪ We have strong support from our current shareholders and we will continue to ensure that our shareholders are prioritised"
Let's hope they can finally walk the talk - talk is cheap and so far they have been big on promises but always missing in carrying out the action... let's wait and see what the rest of this year brings, but don't hold your breath!
GLTAH
.
Ann: Investor Presentation March 2021, page-2
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
-0.005(2.44%) |
Mkt cap ! $211.2M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 20.8¢ | 19.5¢ | $667.5K | 3.320M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 823165 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 168743 | 9 |
View Market Depth
| Last trade - 16.10pm 13/11/2024 (20 minute delay) ? |
| ALA (ASX) Chart |